.K.C.h...C...ren

Size: px
Start display at page:

Download ".K.C.h...C...ren"

Transcription

1 4 quality of life QOL QOL

2 QOL 3

3 QOL 19 mmhg 16 mmhg 14 mmhg

4 QOL QOL QOL QOL QOL QOL QOL

5

6

7

8 QOL 3

9

10 Abraham Wise 1 Nd YAG mw

11 1000 mw Nd YAG Nd YAG Nd YAG 1 3

12 25 mmhg 1 1/4 1/ nm Q YAG selective laser trabeculoplasty SLT 1/ mw

13

14 mw

15 mm 1 1/2 3/ mw 2

16 mw viscocanalostomy

17

18 1 Schlemm Schlemm 2 3 1

19 Collaborative Normal-Tension Glaucoma Study Group: Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures Am J Ophthalmol , Collaborative Normal-Tension Glaucoma Study Group: The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma Am J Ophthalmol The AGIS Investigators: TheAdvanced Glancoma Intervention study AGIS : 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol , Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, et al: The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol ; discussion , Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M: Early Manifest Glaucoma Trial Group: Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol , Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E: Early Manifest Glaucoma Trial Group: Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol , 2003.

.K.C.h...C...ren

.K.C.h...C...ren 3 3 21 2 40 5 7 90 2 up-date 2003 2006 2 2012 3 2012 5 40 5.8 2003 11 40 5.0 2 1 2003 1 3 2 1 2 Primary angle-closure PAC 3 4 2006 3 3 2003 2006 2 2006 2 5 3 1 2. 3. 3 4 icare dynamic contour tonometer

More information

緑内障診療ガイドライン(第3版)

緑内障診療ガイドライン(第3版) 22 日眼会誌 116 巻 1 号 第 4 章 緑内障の治療総論 Ⅰ 緑内障治療の原則. 治療の目的は患者の視機能維持現在, 緑内障治療の目的は, 患者の視機能を維持することである. 視機能の障害は, 個々の患者の quality of life(qol) を大きく損なうことになる. しかし, 治療にあたっては, 治療による副作用や合併症のみならず, 通院や入院に伴う社会的 経済的負担, あるいは失明への不安なども

More information

.K.C.h...C...ren

.K.C.h...C...ren 1 1, 2 4.1 3.0 5.2 3.7 2.8 4.6 3.9 3.2 4.6 0.3 0.0 0.7 0.2 0.0 0.5 0.3 0.1 0.5 3.7 2.7 4.8 3.5 2.6 4.4 3.6 2.9 4.3 0.3 0.0 0.7 0.9 0.5 1.3 0.6 0.4 0.9 0.6 0.2 1.0 0.4 0.1 0.7 0.5 0.2 0.7 5.0 3.9 6.2 5.0

More information

ACTIVE FOCUS

ACTIVE FOCUS ACTIVE FOCUS Am ACTIVE FOCUS 100% ACTIVE FOCUS 1, m x 4 10-3* 0-4 -4 -.5 x 10-3* 4 0 - - -1.5-1 ACTIVEFOCUS -0.5 0 0.5 mm 1 1.5.5 69.4 1 40.5 100 1, -4 -.5 - -1.5-1 -0.5 0 0.5 mm 1 1.5.5 CPD AcyrSof IQ

More information

.indd

.indd Comparative Study of Glaucomatous Findings in Fundus Photography and Humphrey Perimetry Feng SHI, Yoshimi OYA and Katsuhiko NANBA Heidelberg retina tomographyhrt scanning laser polarimetry GDx VCCGDx optical

More information

審査報告書(案)

審査報告書(案) 19 83 7 18 628 1 19 8 3 7 18 6 28 30 MI 31 360 21700BZY00247000 5mm CEA 59 mm 2 50% 80 1. 2. 3 19 8 3 [ ] 7 [ ] [ ] [ ] [ ] 18 6 28 [ ] CEA 49mm 50 80 2 4 carotid endarterectomy CEA 1,2 CEA ECST 3 NASCET

More information

<95DB8C9288E397C389C88A E696E6462>

<95DB8C9288E397C389C88A E696E6462> 2011 Vol.60 No.4 p.332 338 Usefulness of regional education program for dietary salt reduction: Self-monitoring of urinary salt excretion Kenichiro YASUTAKE[1] Kayoko SAWANO[1] Shoko YAMAGUCHI[1] Hiroko

More information

〈論文〉高校生の学校適応と社会的スキルおよびソーシャルサポートとの関連--不登校生徒との比較

〈論文〉高校生の学校適応と社会的スキルおよびソーシャルサポートとの関連--不登校生徒との比較 Social Skills, Social Support and High School Student Adjustment : A Comparison with Truants Kanako OTSUI This study identified the factors that influence how high school students adjust to school and

More information

istent トラベキュラーマイクロバイパス ステントシステム ( 販売名 ) に関する資料 本資料に記載された情報に係る権利及び内容についての責任は申請者にある

istent トラベキュラーマイクロバイパス ステントシステム ( 販売名 ) に関する資料 本資料に記載された情報に係る権利及び内容についての責任は申請者にある istent トラベキュラーマイクロバイパス ステントシステム ( 販売名 ) に関する資料 本資料に記載された情報に係る権利及び内容についての責任は申請者にある 類別 : 医療用品 04 整形用品 一般的名称 : ヘパリン使用眼内ドレーン 販売名 :istent トラベキュラーマイクロバイパスステントシステム 外国製造医療機器製造販売承認申請書 添付資料概要 グラウコスコーポレーション 略語リスト

More information

2

2 1 2 17 1884 2 131 1 1..He lived to serve 2 2 2 2 14,416 104,000 1 QOL Quality of Life 2 21 2013 25 21 3 4 5 QOL 6 QOL QOL 59 1 60 7 QOL QOL 8 2,774 2015 27 5 7 241 2015 27 5 8 12 2015 3 7 58 1,030 113

More information

Vol. No. Honda, et al.,

Vol. No. Honda, et al., A Study of Effects of Foot Bath before Exercise on Fall Prevention Yoko Honda Yoko Aso Aki Ibe Megumi Katayama Tomoko Tamaru Key Words fall prevention, foot bath, elderly, fall prevention programs Honda,

More information

感覚系における人工臓器 ─人工網膜

感覚系における人工臓器 ─人工網膜 人工臓器 最近の進歩 Hiroyuki KANDA, Takashi FUJIKADO 1. はじめに 2. 視覚のなり立ち 図 1 10 著者連絡先 565-0871 2-2 E-mail. kanda@sensory.med.osaka-u.ac.jp 1 3. 視覚障害 Quality of Life QOL 2 1 1 12 18 1 25.5 2 21.0 3 8.8 1) 1 51 New

More information

untitled

untitled The Japanese Association for Behavior Analysis Newsletter, No. 35 The Japanese Association for Behavior Analysis Newsletter, No. 35 The Japanese Association for Behavior Analysis Newsletter, No. 35 Table

More information

21-07_後藤論文.smd

21-07_後藤論文.smd 2015; 21: 5866 Yoichi Goto: Current status and future perspective of cardiac rehabilitation in Japan. J Jpn Coron Assoc 2015; 21: 5866 I 1 1 3 1 2 3 QOL 2 Fig. 1 1 196070 AMI AMI 1980 AMI CABG comprehensive

More information

(1604)活動火口に形成された火口湖における熱活動モニタリング

(1604)活動火口に形成された火口湖における熱活動モニタリング 25 1604 2. 2 2-2 H24 1 10% H24 21 25 1. 2-3 1.1 2 2011 12 3 2012 3 1 30 WEB 2012 5 6 7 5 1 9 2012 3 3 50 1.2 2012 4 70 10 220 MW 2 500-600 MW 1 1 5 m -9 cm 4 2012 2011 3 2011 12 2011 3 29 580 mg/l 2012

More information

橡

橡 TP T-13i AST ALT ALP Y CTP LOH CHE CRP 8.7 id 0.4 mg/d 21 AWL 131U/L 257 LU/L 12 111/L 234 11J/L 344 IU/L 0.30 mid No K a BUN ORE UA 142 meq/1 4.3 meqa 108 meqa 15.8 met! 0.71 mg/di 5.0 mg/d CEA 5_5 n8/m1

More information

2009年133巻3号3月号.indb

2009年133巻3号3月号.indb Folia Pharmacol. Jpn.133 1 2 Chiroscience UCB S RR-..% AA C IC C/A A/ A R- II/ III II/III Chiroscience UCB S 1 - E-mail: koji_taya@maruishi-pharm.co.jp Author: Koji Taya, Satoshi Shimizu Title: Levobupivacaine

More information

Understanding Stem Cell Transplant 2007

Understanding Stem Cell Transplant 2007 Understanding Stem Cell Transplant IMF International Myeloma Foundation 12650 Riverside Drive, Suite 206 North Hollywood, CA 91607 USA Telephone: 800-452-CURE (2873) (USA & Canada) 818-487-7455 Fax: 818-487-7454

More information

Background : There have not been any informations available of whether diuretics may enhance renoprotective effects of ACEI and ARB. Methods Post-hoc analysis of the results of COOPERATE trial, asking

More information

untitled

untitled 5 K 5 3 HP http://www.mhlw.go.jp/bunya/shakaihosho/iryouseido01/taikou03.html 2004 1 2 1 http://www.dm-net.co.jp/calendar/2007/06/005835.php 6 85cm 100cm 2 90cm 2 TG 150mg/dl HDLHDL-C 40mg/dl 130mmHg 85mmHg

More information

Ⅱ Ⅲ Ⅳ Assertive community treatment - Issues from scientific and clinical literature with implications for practice The Impact of Supported Employment and Working on Clinical and

More information

194621 22 50.06 53.96 90.00 28 87.14 85.00 80.00 75.00 70.00 22 53.96 28 80.75 65.00 60.00 55.00 22 50.06 50.00 Quality of Life !! 281026 281026 -6,500-5,500-4,500-3,500-2,500-1,500-500 500 1,500 2,500-6,401-1,281-3,565-2,154-2,265-2,027-1,869-1,657

More information

CLINICAL STUDY 2011 Double blind, randomized, cross over, controlled clinical trial of Symbosial (NaCl + Chitosan 3%) vs NaCl on high blood pressure p

CLINICAL STUDY 2011 Double blind, randomized, cross over, controlled clinical trial of Symbosial (NaCl + Chitosan 3%) vs NaCl on high blood pressure p CLINICAL STUDY 2011 Double blind, randomized, cross over, controlled clinical trial of Symbosial (NaCl + Chitosan 3%) vs NaCl on high blood pressure parameters during the diet and lifestyle improvement

More information

NVISION-K.D cm. SPSS Ver pp.

NVISION-K.D cm. SPSS Ver pp. ICT. pp.. pp. p. pp. pp.. ........ NVISION-K.D cm. SPSS Ver pp. .. ... D.. D.. D.. D.. D.. D p. .. D D........... cyl. cyl.cyl. cyl. D .. D.. D.. D.. D.. D.. D p. D........ D.. D.. D.. D.. D.. D p.....

More information

1

1 1 5% 4% 11% 8% 13% 12% 10% 6% 17% 6% 8% 4% 6% 6% 2% 17% 17% 12% 14% 16% 6% 37% 11% 17% 35% 2 (N=6,239) 0 200 400 600 800 1,000 1,200 1,400 1,600 1,800 1,585 1,126 950 494 345 296 242 263 191 150 131 116

More information

塗装深み感の要因解析

塗装深み感の要因解析 17 Analysis of Factors for Paint Depth Feeling Takashi Wada, Mikiko Kawasumi, Taka-aki Suzuki ( ) ( ) ( ) The appearance and quality of objects are controlled by paint coatings on the surfaces of the objects.

More information

St. Andrew's University NPO NII-Electronic Library Service

St. Andrew's University NPO NII-Electronic Library Service NPO early intervention Edwards At Risk Mental State At Risk Mental State ARMS Yung ARMS Ultra High Risk ARMS Edwards, J., McGorry, P. D. 2002 Implementing Early Intervention is Psychosis, Martin Duriz

More information

untitled

untitled 19 3 ...1...1...3...3...4...5...6...7...8...9...12...14...16...17...17...17...18...19...19...20...20 ...21...21 1.1.1...21 1.1.2...22...23 1.2.1...23 1.2.2...24 1.2.3...24...25 1.3.1...26 1.3.2...27 1.3.3...28

More information

E Societe de Pathologie Infectieuse de Langue Francaise (, 1991) E Spanish Thoracic Society (1992) E American Thoracic Society (ATS : 1993. ü ù2001 ) E British Thoracic Society (1993, ü è2001 ) E Canadian

More information

Therapy for Asthenopia in Cases of Convergence Insufficiency Hiroko TAKASAKI, C.O.J., Nobuko INAGAMI, C.O.J., and Kayoko TAKENAWA, C.O.J.. Orthoptic c

Therapy for Asthenopia in Cases of Convergence Insufficiency Hiroko TAKASAKI, C.O.J., Nobuko INAGAMI, C.O.J., and Kayoko TAKENAWA, C.O.J.. Orthoptic c Therapy for Asthenopia in Cases of Convergence Insufficiency Hiroko TAKASAKI, C.O.J., Nobuko INAGAMI, C.O.J., and Kayoko TAKENAWA, C.O.J.. Orthoptic clinic, Department of Ophthalmology, (Director: Prof

More information

untitled

untitled 186 17 100160250 1 10.1 55 2 18.5 6.9 100 38 17 3.2 17 8.4 45 3.9 53 1.6 22 7.3 100 2.3 31 3.4 47 OR OR 3 1.20.76 63.4 2.16 4 38,937101,118 17 17 17 5 1,765 1,424 854 794 108 839 628 173 389 339 57 6 18613

More information

untitled

untitled 1. 3 14 2. 1 12 9 7.1 3. 5 10 17 8 5500 4. 6 11 5. 1 12 101977 1 21 45.31982.9.4 79.71996 / 1997 89.21983 41.01902 6. 7 5 10 2004 30 16.8 37.5 3.3 2004 10.0 7.5 37.0 2004 8. 2 7 9. 6 11 46 37 25 55 10.

More information

1 2 http://www.japan-shop.jp/ 3 4 http://www.japan-shop.jp/ 5 6 http://www.japan-shop.jp/ 7 2,930mm 2,700 mm 2,950mm 2,930mm 2,950mm 2,700mm 2,930mm 2,950mm 2,700mm 8 http://www.japan-shop.jp/ 9 10 http://www.japan-shop.jp/

More information

(1519) () 1 ( ) () 1 ( ) - 1 - - 2 - (1531) (25) 5 25,000 (25) 5 30,000 25,000 174 3 323 174 3 323 (1532) () 2 () 2-3 - - 4 - (1533) () 1 (2267)204 () (1)(2) () 1 (2267)204 () (1)(2) (3) (3) 840,000 680,000

More information

第18回海岸シンポジウム報告書

第18回海岸シンポジウム報告書 2011.6.25 2011.6.26 L1 2011.6.27 L2 2011.7.6 2011.12.7 2011.10-12 2011.9-10 2012.3.9 23 2012.4, 2013.8.30 2012.6.13 2013.9 2011.7-2011.12-2012.4 2011.12.27 2013.9 1m30 1 2 3 4 5 6 m 5.0m 2.0m -5.0m 1.0m

More information

1 911 34/ 22 1012 2/ 20 69 3/ 22 69 1/ 22 69 3/ 22 69 1/ 22 68 3/ 22 68 1/ 3 8 D 0.0900.129mm 0.1300.179mm 0.1800.199mm 0.1000.139mm 0.1400.409mm 0.4101.199mm 0.0900.139mm 0.1400.269mm 0.2700.289mm

More information

液晶ディスプレイ取説TD-E432/TD-E502/TD-E552/TD-E652/TD-E432D/TD-E502D

液晶ディスプレイ取説TD-E432/TD-E502/TD-E552/TD-E652/TD-E432D/TD-E502D 1 2 3 4 5 6 7 1 2 3 4 5 6 7 2 2 2 1 1 2 9 10 11 12 13 14 15 16 17 1 8 2 3 4 5 6 7 1 2 3 4 5 6 7 8 9 10 9 11 12 13 13 14 15 16 17 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 1 2 3 4 5 6 7 8 9 11 12

More information

1 1 36 223 42 14 92 4 3 2 1 4 3 4 3429 13536 5 6 7 8 9 2.4m/ (M) (M) (M) (M) (M) 6.67.3 6.57.2 6.97.6 7.27.8 8.4 5 6 5 6 5 5 74 1,239 0 30 21 ( ) 1,639 3,898 0 1,084 887 2 5 0 2 2 4 22 1 3 1 ( :) 426 1500

More information

1 C 2 C 3 C 4 C 1 C 2 C 3 C

1 C 2 C 3 C 4 C 1 C 2 C 3 C 1 e N >. C 40 41 2 >. C 3 >.. C 26 >.. C .mm 4 C 106 e A 107 1 C 2 C 3 C 4 C 1 C 2 C 3 C 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124

More information

平成24年財政投融資計画PDF出後8/016‐030

平成24年財政投融資計画PDF出後8/016‐030 24 23 28,707,866 2,317,737 26,390,129 29,289,794 2,899,665 24 23 19,084,525 21,036,598 1952,073 24 23 8,603,613 8,393,427 967,631 925,404 202,440 179,834 217,469 219,963 66,716 64,877 3,160,423 2,951,165

More information

[mm] [mm] [mm] 70 60 50 40 30 20 10 1H 0 18 19 20 21 22 23 24 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 1 2 3 4 5 6 7 8 9 10 11 12 60 50 40 30 20 10 0 18 19 20 21 22 23 24 1 2 3 4

More information

000-.\..

000-.\.. 1 1 1 2 3 4 5 6 7 8 9 e e 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 10mm 150mm 60mm 25mm 40mm 30mm 25 26 27 1 28 29 30 31 32 e e e e e e 33 e 34 35 35 e e e e 36 37 38 38 e e 39 e 1 40 e 41 e 42 43

More information

indd

indd 12 61 1 2011 原著 1)2)5) 1) 1)2) 1)2)5) 1)3)5) 1)2) 1)2)5) 1)2) 1)2) 2) 2) 4) 1) 1) 2) 3) 4) 5) 2010 10 6 2010 12 6 A Comparative Study of the Effect and Discomfort Produced by Pharyngeal Anesthesia with

More information

pp 427 438 2006 Dimensional Change Card Sort ****** ** 2005 9 30 2004 8 2002 4 Zelazo, P. D., Carter, A., Reznick, J. S. & Frye, D. 1997 10 2003 Zelaz

pp 427 438 2006 Dimensional Change Card Sort ****** ** 2005 9 30 2004 8 2002 4 Zelazo, P. D., Carter, A., Reznick, J. S. & Frye, D. 1997 10 2003 Zelaz Title 幼 児 の 実 行 機 能 の 発 達 過 程 : Dimensional Change C を 用 いたルールの 理 解 とその 使 用 に 関 する 検 討 Author(s) 浮 穴, 寿 香 ; 橋 本, 創 一 ; 出 口, 利 定 Citation 東 京 学 芸 大 学 紀 要. 総 合 教 育 科 学 系, 57: 427-438 Issue Date 2006-02-00

More information

32-1_会告.indd

32-1_会告.indd 原 著 Relationship between Urinary Incontinence and Childbirth Among Women who Have Given Birth within the Last Three Years The Role of Midwives in the Prevention and Improvement of Urinary Incontinence

More information

*4 Drug Delivery System original article Cytodegenerative and growth-inhibitory effects on LY-80 cells by methotrexate and 5-fluorouracil in combinati

*4 Drug Delivery System original article Cytodegenerative and growth-inhibitory effects on LY-80 cells by methotrexate and 5-fluorouracil in combinati *4 Drug Delivery System original article Cytodegenerative and growth-inhibitory effects on LY-80 cells by methotrexate and 5-fluorouracil in combination with angiotensin II induced hyperten sion chemotherapy

More information

8 The Bulletin of Meiji University of Integrative Medicine API II 61 ASO X 11 7 X-4 6 X m 5 X-2 4 X 3 9 X 11 7 API 0.84 ASO X 1 1 MR-angio

8 The Bulletin of Meiji University of Integrative Medicine API II 61 ASO X 11 7 X-4 6 X m 5 X-2 4 X 3 9 X 11 7 API 0.84 ASO X 1 1 MR-angio 7-14 2010 1 1 1 2 1 1 1 2 Fontaine II ASO61 3 API ASO ASO ASO API API KKKKKKKKKK ASO Fontaine II API Received April 14, 2009; Accepted July 16, 2009 I arteriosclerosis obliterans: ASO ASO 50 70 1,2 Fontaine

More information

EVALUATION OF NOCTURNAL PENILE TUMESCENCE (NPT) IN THE DIFFERENTIAL DIAGNOSIS OF IMPOTENCE Masaharu Aoki, Yoshiaki Kumamoto, Kazutomi Mohri and Kazunori Ohno Department of Urology, Sapporo Medical College

More information

名称未設定-1

名称未設定-1 Study on Clinical Factors Affecting the Fungal Culture Test - Relevance of Dry Mouth - Yoshiko YAMAMURA, Yukihiro MOMOTA, Hideyuki TAKANO, Koichi KANI, Katsumi MOTEGI, Fumihiro MATSUMOTO, Masayuki AZUMA

More information

20mg #tr#5*xlj lffin&+'.':, t) r+'z)vt '+D#J Centers for Medicare & Medicaid Sewices Garden AS et al. Preliminary results ofradiation Therapy Oncology Group 97-03: a randomized phase II trial of

More information

Perspective-Taking Perspective-Taking.... Vol. No.

Perspective-Taking Perspective-Taking.... Vol. No. Nurses Thinking Process in Understanding Patients Unconscious Denial Tomoko Hayashi Key Words putting oneself in the patient s place, perspective-taking, misunderstand patient s perspective, modifying

More information

Efficacy of Colestimide as a phosphate binder in patients on chronic hemodialysis Toshiyuki Date, Yoshiteru Kawashita, Nobuyoshi Satake Jin-ai-kai Dat

Efficacy of Colestimide as a phosphate binder in patients on chronic hemodialysis Toshiyuki Date, Yoshiteru Kawashita, Nobuyoshi Satake Jin-ai-kai Dat Efficacy of Colestimide as a phosphate binder in patients on chronic hemodialysis Toshiyuki Date, Yoshiteru Kawashita, Nobuyoshi Satake Jin-ai-kai Date Clinic In some patients on chronic hemodialysis,

More information

日本皮膚科学会雑誌第117巻第14号

日本皮膚科学会雑誌第117巻第14号 1 QOL 3 Visual analogue scale VAS 4 2 5 1 表 1 患者背景 背景因子 (n= 143) 例数 背景因子 (n= 143) 例数 性別 年齢 平均値 ±SD 50.4±15.6 最少 19 最高 86 男性 女性 30 歳未満 30~39 歳 40~49 歳 50~59 歳 60~69 歳 70 歳以上 98(68.5%) 45(31.5%) 13( 9.1%)

More information

2001 2003 2005 2006 2007 2008

2001 2003 2005 2006 2007 2008 2001 2003 2005 2006 2007 2008 60 etc. http://nosmoke.hp.infoseek.co.jp/yuugaibussitu.htm http://nosmoke.hp.infoseek.co.jp/yuugaibussitu.htm 23.5% 2.8% 2.8% 3.4% 30.3% 9.9% 11.5% 15.8% AAN 65

More information

<30388DE288E42E696E6464>

<30388DE288E42E696E6464> Doshisha Journal of Health & Sports Science, 1, 53-60, 2009 53 1 Effects of Step Exercise in Healthy Older People Tomoaki Sakai 1 The purpose of this study was to determine the effect of step exercise

More information

v

v v CONTENTS 1 2 7 2 14 COLUMN 15 RAGEAGEs 21 COLUMN 22 26 COLUMN NADPH 28 32 COLUMN GLP1 36 39 COLUMN AGEs 44 46 54 COLUMN GWAS 55 59 3 66 COLUMN 69 COLUMN 1 2 71 vi 4 78 84 89 COLUMN GFR decliner 92 94

More information

居眠り事故を未然に防止するための睡眠・覚醒管理技術の開発

居眠り事故を未然に防止するための睡眠・覚醒管理技術の開発 30 1520 12) 3) 31 4) 10151 23 15 20 3 16 11,400,000 0 11,400,000 17 1,500,000 0 1,500,000 18 1,500,000 0 1,500,000 19 1,600,000 480,000 2,080,000 16,000,000 480,000 16,480,000 1 5 11 1 11 2 23 3 39 1 43

More information

WhitePaper_FSO/01LP013(J)

WhitePaper_FSO/01LP013(J) (Free-Space Optical Laser Safety) 2001 LightPointe. All rights reserved. Freedom Flexibility Fast 1 2 µ 3 4 5 0.78 mw 850 nm 1550 nm : 7mm : 100mm 6 7 8 9 10 11 6260 Lookout Rd., #2 10140 Barnes Canyon

More information

indd

indd Molecular Targeted Therapy for Lung Cancer from a Pharmaceutical Point of Viewe Naho SASAKI epidermal growth factor receptor tyrosine kinase inhibitor :EGFR-TKI vascular endothelial growth factor:vegf

More information

1. King, V. L., Y. Koketsu, D. Reeves, JL. Xue, G. D. Dial.: Management factors associated with swine breeding herd productivity in the USA. Prey. Vet. Med. 35 : 255-264, 1998. 2. Koketsu, Y., J. E. Pettigrew,

More information

06_学術_関節単純X線画像における_1c_梅木様.indd

06_学術_関節単純X線画像における_1c_梅木様.indd Arts and Sciences X The formulation of femoral heard measurement corrected enlargement ratio using hip joints X-ray Imaging 1 2 1 1 1 2 Key words: Bipolar Hip Arthroplasty (BHA) Preoperative planning Enlargement

More information

untitled

untitled ( ) - 1 - - 2 - 38% 26% A) Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma 124 (J Clin Oncol 7: 126-131, 1989) 124 95 29 II 1 2,000mg/m 2 x 4 8g/m

More information

A5 PDF.pwd

A5 PDF.pwd Average Treatment Effect; ATE attributes Randomized Factorial Survey Experiment; RFSE cues ATE ATE Hainmueller et al. 2014 Average Marginal Component Effect ATE 67 4 2017 2 845 , ;, ATE, ;, ;, W 846 67

More information

胆石症

胆石症 ,. vs 64 .. vs. -, Ransohoff DF, Gracie W. Treatment of gallstones. Ann Intern Med ; 119 : - Halldestam I, Enell EL, Kullman E, et al. Development of symptoms and complications in individuals with asymptomatic

More information